Literature DB >> 11700041

Antioxidant and radical scavenging properties of 8-oxo derivatives of xanthine drugs pentoxifylline and lisofylline.

V B Bhat1, K M Madyastha.   

Abstract

The antioxidant and radical scavenging properties of 8-oxo derivatives of pentoxifylline, lisofylline, enprofylline (3-propyl xanthine), and 1,7-dimethyl enprofylline were studied in vitro. The results show that 8-oxopentoxifylline and 8-oxolisofylline are significantly better hydroxyl and peroxyl radical scavengers and more potent inhibitors of t-butylhydroperoxide-induced lipid peroxidation in human erythrocyte membranes than the parent drugs. The hydroxyl radical scavenging property of 8-oxoenprofylline and its analogue 1,7-dimethyl-8-oxoenprofylline is marginally better than their corresponding xanthines. Interestingly, 1,7-dimethyl-8-oxoenprofylline is an effective inhibitor of lipid peroxidation whereas enprofylline, 1,7-dimethylenprofylline, and 8-oxoenprofylline exhibit significantly less activity. All the 8-oxo derivatives tested are better hydroxyl radical scavengers than uric acid, a natural antioxidant and a free radical scavenger in humans. The rate constant for the reaction between 8-oxopentoxifylline and hydroxyl radical is 1.6-4.2 x 10(10) M(-1) s(-1) which is comparable to that of dimethyl sulfoxide (1.4-1.6 x 10(10) M(-1) s(-1)) and better than that of mannitol (1.9-2.5 x 10(9) M(-1) s(-1)), the known hydroxyl radical scavengers. Both 8-oxo pentoxifylline (IC(50), 1.8 +/- 0.08 microM) and 8-oxolisofylline (IC(50), 2.2 +/- 0.13 microM) are as efficient peroxyl radical scavengers as uric acid (IC(50), 1.9 +/- 0.05 microM). The results presented clearly indicate that the anti-inflammatory property of pentoxifylline and lisofylline is exerted more through their 8-oxo derivatives than through the parent drugs. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11700041     DOI: 10.1006/bbrc.2001.5922

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  22 in total

Review 1.  Management strategies for male factor infertility.

Authors:  Gerhard Haidl
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 2.  Pharmacological agents for NASH.

Authors:  Vlad Ratziu
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-10-15       Impact factor: 46.802

3.  Effect of Pentoxifylline on Histological Activity and Fibrosis of Nonalcoholic Steatohepatitis Patients: A One Year Randomized Control Trial.

Authors:  Shahinul Alam; Skm Nazmul Hasan; Golam Mustafa; Mahabubul Alam; Mohammad Kamal; Nooruddin Ahmad
Journal:  J Transl Int Med       Date:  2017-09-30

4.  Topical combinations to treat microvascular dysfunction of chronic postischemia pain.

Authors:  André Laferrière; Rachid Abaji; Cheng-Yu Mark Tsai; J Vaigunda Ragavendran; Terence J Coderre
Journal:  Anesth Analg       Date:  2014-04       Impact factor: 5.108

5.  Topical combinations aimed at treating microvascular dysfunction reduce allodynia in rat models of CRPS-I and neuropathic pain.

Authors:  J Vaigunda Ragavendran; André Laferrière; Wen Hua Xiao; Gary J Bennett; Satyanarayana S V Padi; Ji Zhang; Terence J Coderre
Journal:  J Pain       Date:  2013-01       Impact factor: 5.820

6.  Pentoxifylline decreases oxidized lipid products in nonalcoholic steatohepatitis: new evidence on the potential therapeutic mechanism.

Authors:  Claudia O Zein; Rocio Lopez; Xiaoming Fu; John P Kirwan; Lisa M Yerian; Arthur J McCullough; Stanley L Hazen; Ariel E Feldstein
Journal:  Hepatology       Date:  2012-10       Impact factor: 17.425

7.  Pentoxifylline ameliorates glomerular basement membrane ultrastructural changes caused by gentamicin administration in rats.

Authors:  Nenad Stojiljković; Slavimir Veljković; Dragan Mihailović; Milan Stoiljković; Goran Ranković; Ivan Jovanović; Pavle Randjelović
Journal:  Bosn J Basic Med Sci       Date:  2009-08       Impact factor: 3.363

Review 8.  New treatments for nonalcoholic fatty liver disease.

Authors:  Stephen A Harrison
Journal:  Curr Gastroenterol Rep       Date:  2006-02

Review 9.  Molecular mechanisms and the role of saturated fatty acids in the progression of non-alcoholic fatty liver disease.

Authors:  Alexandra K Leamy; Robert A Egnatchik; Jamey D Young
Journal:  Prog Lipid Res       Date:  2012-11-23       Impact factor: 16.195

10.  Amelioration of steatohepatitis with pentoxifylline in a novel nonalcoholic steatohepatitis model induced by high-fat diet.

Authors:  Mehmet Yalniz; I Halil Bahçecioğlu; Nalan Kuzu; Selman Celebi; Hüseyin Ataseven; Bilal Ustündağ; Ibrahim H Ozercan; Kazim Sahin
Journal:  Dig Dis Sci       Date:  2007-04-06       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.